SOADOR
AUPH icon

State of Alaska Department of Revenue’s Aurinia Pharmaceuticals AUPH Stock Holding History

State of Alaska Department of Revenue’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Hold
8,543
– – ﹤0.01% 1701
2026
Q1 		$126K Hold
8,543
– – ﹤0.01% 1720
2025
Q4 		$136K Buy
8,543
+265
+3% +$3.76K ﹤0.01% 1730
2025
Q3 		$91K Buy
+8,278
New +$90.4K ﹤0.01% 1689

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return

State of Alaska Department of Revenue's AUPH Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 8,543 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1701.

State of Alaska Department of Revenue first reported a position in AUPH in Q3 2025 and has held it in 4 quarters since. 167 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • State of Alaska Department of Revenue held 8,543 shares of Aurinia Pharmaceuticals worth $144K as of Q2 2026.
  • State of Alaska Department of Revenue left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1701 holding.
  • State of Alaska Department of Revenue first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.